| abstract |
Provided herein are diaminopyrimidyl Compounds having the following structures: n n n n n n n n n n n n wherein X, L, R 1 , and R 2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta. |